The majority of clinical studies reported have relied upon positive selection of tumour cells that express a single biomarker.6, 7, 8, 9, 10, 11, 12, 13 The antigen chosen most commonly is epithelial cell adhesion molecule (EpCAM). The gene discussed is EPCAM; the disease is neoplasm.